OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The evolution of immune checkpoint inhibitor combinations in advanced hepatocellular carcinoma – A systematic review
Brandon M. Meyers, Jennifer J. Knox, David Liu, et al.
Cancer Treatment Reviews (2023) Vol. 118, pp. 102584-102584
Closed Access | Times Cited: 9
Brandon M. Meyers, Jennifer J. Knox, David Liu, et al.
Cancer Treatment Reviews (2023) Vol. 118, pp. 102584-102584
Closed Access | Times Cited: 9
Showing 9 citing articles:
Using Combination therapy to overcome diverse challenges of Immune Checkpoint Inhibitors treatment
Racheli Birnboim-Perach, Itai Benhar
International Journal of Biological Sciences (2024) Vol. 20, Iss. 10, pp. 3911-3922
Open Access | Times Cited: 11
Racheli Birnboim-Perach, Itai Benhar
International Journal of Biological Sciences (2024) Vol. 20, Iss. 10, pp. 3911-3922
Open Access | Times Cited: 11
Immunotherapy in liver cancer: overcoming the tolerogenic liver microenvironment
Yanju Liu, Hongyuan Yang, Tian Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Yanju Liu, Hongyuan Yang, Tian Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Outcome prediction model for patients with unresectable hepatocellular carcinoma treated with targeted therapy
Qiang Ruan, Xiaohui Wang, Qiang Li, et al.
(2025)
Closed Access
Qiang Ruan, Xiaohui Wang, Qiang Li, et al.
(2025)
Closed Access
Exploiting the immune system in hepatic tumor targeting: Unleashing the potential of drugs, natural products, and nanoparticles
Chou‐Yi Hsu, Mohammed Ahmed Mustafa, Ashwani Kumar, et al.
Pathology - Research and Practice (2024) Vol. 256, pp. 155266-155266
Closed Access | Times Cited: 3
Chou‐Yi Hsu, Mohammed Ahmed Mustafa, Ashwani Kumar, et al.
Pathology - Research and Practice (2024) Vol. 256, pp. 155266-155266
Closed Access | Times Cited: 3
Ru(II)-based complexes containing 2-thiouracil derivatives suppress liver cancer stem cells by targeting NF-κB and Akt/mTOR signaling
Larissa M. Bomfim, Sara P. Neves, Amanda M. R. M. Coelho, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Larissa M. Bomfim, Sara P. Neves, Amanda M. R. M. Coelho, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Similar usage of T‐cell receptor β‐chain between tumor and adjacent normal tissue in hepatocellular carcinoma
Jiezuan Yang, Shaoyan Xu, Dangsheng Xiao, et al.
Cancer Medicine (2024) Vol. 13, Iss. 16
Open Access | Times Cited: 2
Jiezuan Yang, Shaoyan Xu, Dangsheng Xiao, et al.
Cancer Medicine (2024) Vol. 13, Iss. 16
Open Access | Times Cited: 2
Changes in Serum Interleukin-8 Levels Predict Response to Immune Checkpoint Inhibitors Immunotherapy in Unresectable Hepatocellular Carcinoma Patients
Jiao Zhang, Yi Yin, Jiliang Tang, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 3397-3406
Open Access | Times Cited: 2
Jiao Zhang, Yi Yin, Jiliang Tang, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 3397-3406
Open Access | Times Cited: 2
DPPX-Antibody-Associated Encephalitis Induced by Immune Checkpoint Inhibitor Treatment for Advanced Hepatocellular Carcinoma
Yi Yang, S. Li, Dong Zhou, et al.
Journal of Clinical Neurology (2024) Vol. 20, Iss. 2, pp. 214-214
Open Access | Times Cited: 1
Yi Yang, S. Li, Dong Zhou, et al.
Journal of Clinical Neurology (2024) Vol. 20, Iss. 2, pp. 214-214
Open Access | Times Cited: 1
Efficacy and safety of PD-1 inhibitors plus anti-angiogenesis tyrosine kinase inhibitors with or without transarterial chemo(embolization) for unresectable hepatocellular carcinoma: a meta-analysis
Yue Chen, Luyao Jia, Yu Li, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Yue Chen, Luyao Jia, Yu Li, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Impact of race, ethnicity, and social determinants on outcomes following immune checkpoint therapy
Rahul Nayak, Meili Aiello, Laneisha Maldonado, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 10, pp. e010116-e010116
Open Access
Rahul Nayak, Meili Aiello, Laneisha Maldonado, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 10, pp. e010116-e010116
Open Access
